Novavax (NVAX) Net Margin (2010 - 2026)

Novavax's Net Margin history runs 17 years deep, the most recent figure standing at 6.8% for Q1 2026.

• In Q1 2026, Net Margin fell 8460.0% year-over-year to 6.8%; the TTM figure through Mar 2026 stood at 16.51% (down 5465.0% YoY), while the FY2025 annual figure was 39.19%, up 6668.0% from the prior year.
• Net Margin was 6.8% for Q1 2026 at Novavax, down from 11.91% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 77.8% in Q1 2025 to a low of 363.07% in Q1 2023.
• Historically, Net Margin has averaged 76.3% across 5 years, with a median of 50.99% in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Margin jumped 32987 bps in 2022, then plunged 39196 bps in 2023.
• A 5-year view of Net Margin shows it stood at 50.99% in 2022, then retreated by 20 bps to 61.23% in 2023, then tumbled by 50 bps to 91.76% in 2024, then soared by 113 bps to 11.91% in 2025, then slumped by 157 bps to 6.8% in 2026.
• The last three Net Margin figures came in at 6.8% (Q1 2026), 11.91% (Q4 2025), and 287.29% (Q3 2025), per Business Quant data.